Sema4 said Tuesday that it will acquire GeneDx from Opko Health for approximately $623 million in cash, stock consideration, and milestone payments.

The Hurun Research Institute today released the Hurun China 500 Most Valuable Private Companies 2021, a list of the Top 500 China non-state-controlled enterprises ranked according to their value.

Threads or earphone cables placed in tight spaces get easily tangled. On the contrary, our body's long and loose DNA packs into rod-shaped chromosomes one-millionth its size when the cell divides.

A new study led by researchers at Harvard Medical School has identified a set of cellular receptors for at least three related alphaviruses shared across mosquitoes, humans, and animals that host these viruses.

Wuhan Thalys Biotechnology Co.,Ltd. ("Thalys") announced that it has signed a contract with Norwegian high-tech molecular diagnostic company Genetic Analysis ("GA") for the laboratory self-built project testing (LDT) for the Chinese market.

Specific nuclear proteins act as a glue to pack genetic material in an absurdly small space in the human body. Proteins “gluing” DNA are called linker histones, and hold their secret in their electric charge. They are strongly positively charged, fusing to the strongly negatively charged DNA.

Expects Q4 2021 revenue of $29-31 million; Full year 2021 revenue of $109-111 million

ISB-led study shows unvaccinated pregnant people with COVID-19 are more likely to have poor birth outcomes even if they did not experience severe respiratory problems during infection.

According to public statistics, the transaction value of the global TOP10 healthcare M&A deals in 2021 will all be more than $3 billion, of which Thermo Fisher’s acquisition of PPD for $17.4 billion ranks first

Illumina announced a bevy of new business partnerships, products, and technology advances Monday at the 2022 JP Morgan Healthcare Conference, held virtually this week.

SQI Diagnostics said on Monday that it has signed a definitive agreement to acquire Precision Biomonitoring's SARS-CoV-2 testing business and related molecular diagnostic technology for $6.825 million in cash and stock.

A variety of diagnostic companies, including Danaher, PerkinElmer, Cue Health, T2 Biosystems, SomaLogic, and Fluidigm, announced preliminary earnings results for the fourth quarter and full year 2021 on Tuesday.

Due to the substantial increase in overseas sales of the COVID-19 Test kit launched in 2021, many listed IVD companies estimate that their profits will surge in 2021.

Scientists have just slotted into place a big piece of the puzzle that explains how our blood cells mount their first line of defence against viruses. They hope this discovery will help them one day better control the response to either boost it or calm it down as appropriate.

Multiple diagnostic firms released preliminary earnings results for the fourth quarter and full year of 2021 on Monday, including CareDx, Castle Biosciences, Lucira Health, OpGen, Adaptive Biotechnologies, and Sema4.